The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Darunavir Mylan



Mylan Pharmaceuticals LimitedEU/1/16/1140/012-021

Main Information

Trade NameDarunavir Mylan
Active SubstancesDarunavir
Dosage FormFilm-coated tablet
Licence HolderMylan Pharmaceuticals Limited
Licence NumberEU/1/16/1140/012-021

Group Information

ATC CodeJ05AE Protease inhibitors
J05AE10 darunavir

Status

License statusAuthorised
Licence Issued04/01/2017
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back